Metabolic activity in skeletal muscles of patients with non-hypoxaemic chronic obstructive pulmonary disease studied by 31P-magnetic resonance spectroscopy

Respirology

Volumn 10, Issue 2, 2005, Pages 164-170

  Hamaoka, Tomoko ^a   Tatsumi, Koichiro ^a   Saito, Yoshiichito ^a   Arai, Yasuhiro ^a   Horie, Yoshimasa ^a   Masuyama, Shigeru ^a   Tanabe, Nobuhiro ^a   Takiguchi, Yuichi ^a   Ikehira, Hiroo ^a   Obata, Takayuki ^b   Sasaki, Yasuhito ^b   Tanada, Syuzi ^b   Kuriyama, Takayuki ^a  

^a CHIBA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

Chronic obstructive pulmonary disease; Energy metabolism; Exercise; Hypoxaemia; Magnetic resonance spectroscopy

Indexed keywords

CREATINE PHOSPHATE; PHOSPHATE;

ADULT; AGED; ARTICLE; CELL PH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; EXERCISE; GASTROCNEMIUS MUSCLE; HUMAN; HYPOXEMIA; MALE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SKELETAL MUSCLE;

AGED; ANOXIA; EXERCISE; HUMANS; JAPAN; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; MUSCLE, SKELETAL; PHOSPHATES; PHOSPHOCREATINE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 21044440424     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2005.00696.x     Document Type: Article

References (26)

1. 31P-NMR study of skeletal muscle metabolism in patients with chronic respiratory impairment. Am. Rev. Respir. Dis. 1992; 146: 1019-24.
2. 31P-nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with chronic lung disease and congestive heart failure. Eur. Respir. J. 1992; 5: 163-9.
3. Thompson CH, Davies RJ, Kemp GJ, Taylor DJ, Radda GK, Rajagopalan B. Skeletal muscle metabolism during exercise and recovery in patients with respiratory failure. Thorax 1993; 48: 486-90.
4. Wuyam B, Payen JF, Levy P et al. Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease. Eur. Respir. J. 1992; 5: 157-62.
5. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1995; 152: S77-120.
6. 31P nuclear magnetic resonance study. Mol. Biol. Med. 1983; 1: 77-94.
7. Payen JF, Wuyam B, Levy P et al. Muscular metabolism during oxygen supplementation in patients with chronic hypoxemia. Am. Rev. Respir. Dis. 1993; 147: 592-8.
8. 31P-MRS. J. Appl. Physiol. 1995; 78: 2218-27.
9. Larsson L, Ansved T. Effects of long-term physical training and detraining on enzyme histochemical and functional skeletal muscle characteristic in man. Muscle Nerve 1985; 8: 714-22.
10. Muers MF, Green JH. Weight loss in chronic obstructive pulmonary disease. Eur. Respir. J. 1993; 6: 729-34.
11. Nishio ML, Jeejeebhoy KN. Effect of malnutrition on aerobic and anaerobic performance of fast- and slow-twitch muscles of rats. JPEN J. Parenter. Enteral Nutr. 1992; 16: 219-25.
12. Palange P, Forte S, Felli A, Galassetti P, Serra P, Carlone S. Nutritional state and exercise tolerance in patients with COPD. Chest 1995; 107: 1206-12.
13. Houston CS. Operation Everest one and two. Studies of acclimatization to simulated high altitude. Respiration 1997; 64: 398-406.
14. Tanaka M, Mizuta K, Koba F, Ohira Y, Kobayashi T, Honda Y. Effects of exposure to hypobaric-hypoxia on body weight, muscular and hematological characteristics, and work performance in rats. Jpn. J. Physiol. 1997; 47: 51-7.
15. Decramer M, de Bock V, Dom R. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1996; 153: 1958-64.
16. Klein CS, Marsh GD, Petrella RJ, Rice CL. Muscle fiber number in the biceps brachii muscle of young and old men. Muscle Nerve 2003; 28: 62-8.
17. Jakobsson P, Jorfeldt L, Brundin A. Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. Eur. Respir. J. 1990; 3: 192-6.
18. Quistorff B, Johansen L, Sahlin K. Absence of phosphocreatine resynthesis in human calf muscle during ischaemic recovery. Biochem. J. 1993; 291: 681-6.
19. Bernard S, LeBlanc P, Whittom F et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 158: 629-34.
20. Whittom F, Jobin J, Simard PM et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med. Sci. Sports Exerc. 1998; 30: 1467-74.
21. Maltais F, Simard AA, Simard C, Jobin J, Desgagnes P, LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am. J. Respir. Crit. Care Med. 1996; 153: 288-93.
22. Katz A, Sahlin K. Regulation of lactic acid production during exercise. J. Appl. Physiol. 1988; 65: 509-18.
23. Conley KE, Kushmerick MJ, Jubrias SA. Glycolysis is independent of oxygenation state in stimulated human skeletal muscle in vivo. J. Physiol. 1998; 511: 935-45.
24. 31P-magnetic resonance spectroscopy-surface electromyogram (MRS-SEMG) study. Clin. Sci. 1998; 94: 279-86.
25. 2. J. Appl. Physiol. 1998; 85: 1457-63.
26. Chung Y, Sharman R, Carlsen R, Unger SW, Larson D, Jue T. Metabolic fluctuation during a muscle contraction cycle. Am. J. Physiol. 1998; 274: C846-52.